Inefficient antigen presentation via the IgA Fc receptor (FcαRI) on dendritic cells

被引:14
作者
Otten, Marielle A.
Groenveld, Irene
van de Winkel, Jan G. J.
van Egmond, Marjolein
机构
[1] VUMC, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands
[2] UMC, Dept Immunol, Immunotherapy Lab, Utrecht, Netherlands
[3] Genmab, Utrecht, Netherlands
[4] VUMC, Dept Surg Oncol, Amsterdam, Netherlands
关键词
antigen presentation; dendritic cell; Fc receptor; IgA;
D O I
10.1016/j.imbio.2006.05.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DC) are professional antigen presenting cells that can induce and regulate adaptive immune responses. For that reason, DC are attractive candidates for vaccination strategies. Recently, expression of the IgA Fc receptor (Fc alpha RI, C1389) was observed on DC, which activation led to DC maturation. We have investigated the potential of DC Fc alpha RI as a target molecule for vaccination against cancer. Fc alpha RI expression was observed on human blood myeloid DC. Furthermore, expression of Fc alpha RI was low on immature DC, cultured from either human monocytes or Fc alpha RI transgenic (Tg) mouse bone marrow cells. Addition of TNF-alpha to culture regimes of both human and mouse DC led to more semi-mature DC, on which Fc alpha RI expression was slightly upregulated. Fc alpha RI on both human and Fc alpha RI Tg mouse DC was internalized after receptor crosslinking. Antigen presentation, measured in Fc alpha RI Tg mouse DC, was however minimal. As antigen presentation is crucial to elicit effective T cell responses, these data suggest that targeting of DC Fc alpha RI is not optimal for DC vaccination strategies. (c) 2006 Elsevier GmbH. All rights reserved.
引用
收藏
页码:503 / 510
页数:8
相关论文
共 32 条
[1]   Origin, precursors and differentiation of mouse dendritic cells [J].
Ardavín, C .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :582-590
[2]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[3]   Dendritic cells as therapeutic vaccines against cancer [J].
Banchereau, J ;
Palucka, AK .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) :296-306
[4]   The role of tumor necrosis factor α in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro [J].
Chen, BG ;
Shi, YJ ;
Smith, JD ;
Choi, D ;
Geiger, JD ;
Mulé, JJ .
BLOOD, 1998, 91 (12) :4652-4661
[5]   TNF skews monocyte differentiation from macrophages to dendritic cells [J].
Chomarat, P ;
Dantin, C ;
Bennett, L ;
Banchereau, J ;
Palucka, AK .
JOURNAL OF IMMUNOLOGY, 2003, 171 (05) :2262-2269
[6]   BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood [J].
Dzionek, A ;
Fuchs, A ;
Schmidt, P ;
Cremer, S ;
Zysk, M ;
Miltenyi, S ;
Buck, DW ;
Schmitz, J .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6037-6046
[7]   Dendritic cell immunotherapy: mapping the way [J].
Figdor, CG ;
de Vries, IJM ;
Lesterhuis, WJ ;
Melief, CJM .
NATURE MEDICINE, 2004, 10 (05) :475-480
[8]   A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes [J].
Geissmann, F ;
Launay, P ;
Pasquier, B ;
Lepelletier, Y ;
Leborgne, M ;
Lehuen, A ;
Brousse, N ;
Monteiro, RC .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :346-352
[9]   Control of cross-presentation during dendritic cell maturation [J].
Gil-Torregrosa, BC ;
Lennon-Duménil, AM ;
Kessler, B ;
Guermonprez, P ;
Ploegh, HL ;
Fruci, D ;
Van Endert, P ;
Amigorena, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :398-407
[10]   Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation [J].
Heystek, HC ;
Moulon, C ;
Woltman, AM ;
Garonne, P ;
van Kooten, C .
JOURNAL OF IMMUNOLOGY, 2002, 168 (01) :102-107